OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

BeiGene Ltd/  US07725L1026  /

IEX
17/05/2024  21:59:21 Chg. +2.19 Volume Bid- Ask- High Low
173.13USD +1.28% 11,319
Turnover: 1.96 mill.		 -Bid Size: - -Ask Size: - 175.90 170.00
GlobeNewswire 14/05 SELLAS Life Sciences Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 02/05 Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results
GlobeNewswire 02/05 SpringWorks Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Business...
GlobeNewswire 30/04 Zymeworks Announces Participation in Upcoming Investor Conferences
GlobeNewswire 11/04 Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
GlobeNewswire 28/03 SELLAS Life Sciences Reports Full Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire 28/03 Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlight...
GlobeNewswire 28/03 Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors
GlobeNewswire 27/03 Zymeworks Announces Participation in Upcoming Investor Conferences
GlobeNewswire 06/03 Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 05/03 Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the ...
GlobeNewswire 27/02 MAIA Biotechnology Appoints Leading Immuno-Oncology Scientist Dr. Remus Vezan as Scientific Advisor
GlobeNewswire 27/02 SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights ...
GlobeNewswire 27/02 Zymeworks Announces Participation in Upcoming Investor Conferences
GlobeNewswire 14/02 Zymeworks To Host Fourth Quarter and Full Year 2023 Results Conference Call
GlobeNewswire 08/02 Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors
GlobeNewswire 31/01 Zymeworks Announces Participation in Upcoming Investor Conferences
GlobeNewswire 08/01 SpringWorks Therapeutics Highlights 2023 Accomplishments and Anticipated Milestones for 2024 at the ...
GlobeNewswire 04/01 Zymeworks Outlines Strategic Priorities and Outlook for 2024 and 2025
GlobeNewswire 04/01 Zymeworks Announces Additional Leadership Appointments
GlobeNewswire 26/12/2023 Zymeworks Announces $50 Million Private Placement to EcoR1 Capital
GlobeNewswire 15/12/2023 Zymeworks Added to Nasdaq Biotechnology Index
GlobeNewswire 30/11/2023 Zymeworks Announces Participation in Upcoming Investor Conference
GlobeNewswire 07/11/2023 Zymeworks Provides Corporate Update and Reports Third Quarter 2023 Financial Results
GlobeNewswire 07/11/2023 Adaptive Biotechnologies Announces New Translational Collaboration to Measure Minimal Residual Disea...